Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
NASDAQInformation TechnologySemiconductorsSnapshot 2026-11-05
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
3.17 → 3.17 EPS · FY ending Dec 31, 2027 · 2 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 6, 2026 to Nov 5, 2026: (new ÷ prior − 1). Contributor count changed from 2 to 2; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for VECO yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Non-GAAP diluted EPS reaches at least $1.50 in 2026 | A primary condition in Veeco Instruments Inc.'s published investment case. The stated target is >= $1.50 per share. | Broken | EPS falls below $1.50 in FY26 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
VECO is a growth-oriented semiconductor equipment business with a multi-year view tied to AI and high-performance computing demand. Its thesis state is intact, though confidence is medium and the risk label has recently risen from elevated to high.
The valuation is expensive versus peers, with a 1.31 premium, and the evidence points to expectations that leave a modest gap. The model labels the setup as justified rather than highly fragile, but the valuation still depends on execution supporting the growth story.
Near term, revenue growth has been supported by AI and high-performance computing demand, rising from $158.3 million in the first quarter of 2026 to $193.5 million in the second. Management has reiterated 2026 revenue guidance of $740 million to $810 million, but execution evidence is mixed after two recent earnings misses followed by an August beat. Risk is high, and a guidance cut on the next call would be a meaningful negative.
For the multi-year thesis, key tests are whether revenue growth continues and whether VECO completes its planned merger with Axcelis in the second half of 2026, pending regulatory and shareholder approvals. Near-term sector conditions also matter: easing rates or stabilization among major technology companies could support the sector, while weaker guidance could pressure the business outlook.
Over the next 1 to 3 years, VECO’s growth case rests on AI and high-performance computing demand, delivery against guidance, and merger completion. The thesis remains intact, but the expensive valuation and high risk make execution central. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| A supporting condition in Veeco Instruments Inc.'s published investment case. The stated target is >= $170 million. |
| Broken |
| Q2 2026 revenue falls below $170 million |
Revenue: $209.384M FY2026-Q3; GAAP. Published target: >= $170 million. The stored target says 2026-Q2; this source reports FY2026-Q3. Fiscal/calendar alignment needs review. Nov 4, 2026209,384,000 USD · source valueLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Annual revenue reaches at least $740 million in 2026 | A primary condition in Veeco Instruments Inc.'s published investment case. The stated target is >= $740 million. | Intact | Annual revenue falls below $740 million in FY26 | Revenue: $209.384M FY2026-Q3; GAAP. Published target: >= $740 million. Annual target cannot be compared with a quarterly or TTM observation. Nov 4, 2026209,384,000 USD · source valueLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Price remains within 20% above fair value | A supporting condition in Veeco Instruments Inc.'s published investment case. The stated target is <= 20% above fair value. | Broken | Price exceeds 20% above fair value for more than one month | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$3.34 → $3.17 · observed estimates
$1.06B → $1.11B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $3.34 | $1,062,522,688 | 2 / 3 |
| 2026-07-25 | $3.04 | $1,002,286,690 | 5 / 4 |
| 2026-07-26 | $3.34 | $1,062,522,688 | 2 / 3 |
| 2026-07-27 | $3.04 | $1,002,286,690 | 5 / 4 |
| 2026-07-28 | $3.04 | $1,002,286,690 | 5 / 4 |
| 2026-07-29 | $3.34 | $1,062,522,688 | 2 / 3 |
| 2026-07-30 | $3.04 | $1,002,286,690 | 5 / 4 |
| 2026-07-31 | $3.04 | $1,002,286,690 | 5 / 4 |
| 2026-08-01 | $3.34 | $1,062,522,688 | 2 / 3 |
| 2026-08-02 | $3.34 | $1,062,522,688 | 2 / 3 |
| 2026-08-03 | $3.04 | $1,002,286,690 | 5 / 4 |
| 2026-08-04 | $3.04 | $1,002,286,690 | 5 / 4 |
| 2026-08-05 | $3.34 | $1,062,522,688 | 2 / 3 |
| 2026-08-06 | $3.34 | $1,062,522,688 | 2 / 3 |
| 2026-08-08 | $3.14 | $1,068,022,688 | 2 / 3 |
| 2026-08-09 | $3.04 | $1,002,286,690 | 5 / 4 |
| 2026-08-10 | $3.04 | $1,002,286,690 | 5 / 4 |
| 2026-08-12 | $3.14 | $1,068,022,688 | 2 / 3 |
| 2026-08-13 | $2.92 | $1,024,848,860 | 5 / 4 |
| 2026-08-14 | $3.14 | $1,068,022,688 | 2 / 3 |
| 2026-08-15 | $3.14 | $1,068,022,688 | 2 / 3 |
| 2026-08-16 | $3.14 | $1,068,022,688 | 2 / 3 |
| 2026-08-17 | $3.14 | $1,068,022,688 | 2 / 3 |
| 2026-08-18 | $3.14 | $1,068,022,688 | 2 / 3 |
| 2026-08-19 | $3.14 | $1,068,022,688 | 2 / 3 |
| 2026-08-20 | $3.17 | $1,085,084,859 | 2 / 3 |
| 2026-08-21 | $3.17 | $1,085,084,859 | 2 / 3 |
| 2026-08-22 | $3.17 | $1,085,084,859 | 2 / 3 |
| 2026-08-23 | $3.17 | $1,085,084,859 | 2 / 3 |
| 2026-08-24 | $3.17 | $1,085,084,859 | 2 / 3 |
| 2026-08-25 | $3.17 | $1,085,084,859 | 2 / 3 |
| 2026-08-26 | $3.17 | $1,085,084,859 | 2 / 3 |
| 2026-08-27 | $3.17 | $1,085,084,859 | 2 / 3 |
| 2026-08-28 | $3.17 | $1,085,084,859 | 2 / 3 |
| 2026-08-29 | $3.17 | $1,085,084,859 | 2 / 3 |
| 2026-08-30 | $3.17 | $1,085,084,859 | 2 / 3 |
| 2026-08-31 | $3.17 | $1,085,084,859 | 2 / 3 |
| 2026-09-01 | $3.17 | $1,085,084,859 | 2 / 3 |
| 2026-09-02 | $3.17 | $1,085,084,859 | 2 / 3 |
| 2026-09-03 | $3.17 | $1,085,084,859 | 2 / 3 |
| 2026-09-04 | $3.17 | $1,085,084,859 | 2 / 3 |
| 2026-09-05 | $3.17 | $1,085,084,859 | 2 / 3 |
| 2026-09-06 | $3.17 | $1,085,084,859 | 2 / 3 |
| 2026-09-07 | $3.17 | $1,085,084,859 | 2 / 3 |
| 2026-09-08 | $3.17 | $1,085,084,859 | 2 / 3 |
| 2026-09-09 | $3.17 | $1,085,084,859 | 2 / 3 |
| 2026-09-10 | $3.17 | $1,085,084,859 | 2 / 3 |
| 2026-09-11 | $3.17 | $1,085,084,859 | 2 / 3 |
| 2026-09-12 | $3.17 | $1,085,084,859 | 2 / 3 |
| 2026-09-13 | $3.17 | $1,085,084,859 | 2 / 3 |
| 2026-09-14 | $3.17 | $1,085,084,859 | 2 / 3 |
| 2026-09-15 | $3.17 | $1,085,084,859 | 2 / 3 |
| 2026-09-16 | $3.17 | $1,085,084,859 | 2 / 3 |
| 2026-09-17 | $3.17 | $1,085,084,859 | 2 / 3 |
| 2026-09-18 | $3.17 | $1,085,084,859 | 2 / 3 |
| 2026-09-19 | $3.17 | $1,085,084,859 | 2 / 3 |
| 2026-09-20 | $3.17 | $1,085,084,859 | 2 / 3 |
| 2026-09-21 | $3.17 | $1,085,084,859 | 2 / 3 |
| 2026-09-22 | $3.17 | $1,085,084,859 | 2 / 3 |
| 2026-09-23 | $3.17 | $1,085,084,859 | 2 / 3 |
| 2026-09-24 | $3.17 | $1,085,084,859 | 2 / 3 |
| 2026-09-25 | $3.17 | $1,085,084,859 | 2 / 3 |
| 2026-09-26 | $3.17 | $1,085,084,859 | 2 / 3 |
| 2026-09-27 | $3.17 | $1,085,084,859 | 2 / 3 |
| 2026-09-28 | $3.17 | $1,085,084,859 | 2 / 3 |
| 2026-09-29 | $3.17 | $1,085,084,859 | 2 / 3 |
| 2026-09-30 | $3.17 | $1,085,084,859 | 2 / 3 |
| 2026-10-01 | $3.17 | $1,085,084,859 | 2 / 3 |
| 2026-10-02 | $3.17 | $1,085,084,859 | 2 / 3 |
| 2026-10-03 | $3.17 | $1,085,084,859 | 2 / 3 |
| 2026-10-04 | $3.17 | $1,085,084,859 | 2 / 3 |
| 2026-10-05 | $3.17 | $1,085,084,859 | 2 / 3 |
| 2026-10-06 | $3.17 | $1,085,084,859 | 2 / 3 |
| 2026-10-07 | $3.17 | $1,085,084,859 | 2 / 3 |
| 2026-10-08 | $3.17 | $1,085,084,859 | 2 / 3 |
| 2026-10-09 | $3.17 | $1,106,446,479 | 2 / 3 |
| 2026-10-10 | $3.17 | $1,106,446,479 | 2 / 3 |
| 2026-10-11 | $3.17 | $1,106,446,479 | 2 / 3 |
| 2026-10-12 | $3.17 | $1,106,446,479 | 2 / 3 |
| 2026-10-13 | $3.17 | $1,106,446,479 | 2 / 3 |
| 2026-10-14 | $3.17 | $1,106,446,479 | 2 / 3 |
| 2026-10-15 | $3.17 | $1,106,446,479 | 2 / 3 |
| 2026-10-16 | $3.17 | $1,106,446,479 | 2 / 3 |
| 2026-10-17 | $3.17 | $1,106,446,479 | 2 / 3 |
| 2026-10-18 | $3.17 | $1,106,446,479 | 2 / 3 |
| 2026-10-19 | $3.17 | $1,106,446,479 | 2 / 3 |
| 2026-10-20 | $3.17 | $1,106,446,479 | 2 / 3 |
| 2026-10-21 | $3.17 | $1,106,446,479 | 2 / 3 |
| 2026-10-22 | $3.17 | $1,106,446,479 | 2 / 3 |
| 2026-10-23 | $3.17 | $1,106,446,479 | 2 / 3 |
| 2026-10-24 | $3.17 | $1,106,446,479 | 2 / 3 |
| 2026-10-25 | $3.17 | $1,106,446,479 | 2 / 3 |
| 2026-10-26 | $3.17 | $1,106,446,479 | 2 / 3 |
| 2026-10-27 | $3.17 | $1,106,446,479 | 2 / 3 |
| 2026-10-28 | $3.17 | $1,106,446,479 | 2 / 3 |
| 2026-10-29 | $3.17 | $1,106,446,479 | 2 / 3 |
| 2026-10-30 | $3.17 | $1,106,446,479 | 2 / 3 |
| 2026-10-31 | $3.17 | $1,106,446,479 | 2 / 3 |
| 2026-11-01 | $3.17 | $1,106,446,479 | 2 / 3 |
| 2026-11-02 | $3.17 | $1,106,446,479 | 2 / 3 |
| 2026-11-03 | $3.17 | $1,106,446,479 | 2 / 3 |
| 2026-11-04 | $3.17 | $1,106,446,479 | 2 / 3 |
| 2026-11-05 | $3.17 | $1,106,446,479 | 2 / 3 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 2 Buy / Strong Buy · 2 Hold · 0 Sell / Strong Sell
Recent actions · Oct 7–Nov 5 · 0 recorded
0 raises · 0 cuts · 0 unchanged · 1 without a comparable prior
Oct 7, 2026–Nov 5, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earnings4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.